Jan Emmerechts
Jan Emmerechts publishes mostly in Hematology, Health, Toxicology and Mutagenesis and Genetics, on topics such as Air Quality and Health Impacts, Blood Coagulation and Thrombosis Mechanisms and Blood properties and coagulation.
- World rank
- #4,015,229 of 7,710,434 ranked researchers
- Rank in Belgium
- #36,103 of 67,186
- Works
- 55
- Citations
- 1k
- Citations per work
- 18.7
What does Jan Emmerechts research?
Jan Emmerechts's work is mostly in Medicine (34%), Environmental Science (12%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2748.9%
- Health Sciences1934.1%
- Medicine1934.1%
- Physical Sciences611.6%
- Environmental Science611.6%
- Life Sciences35.4%
- 1Hematology18% of their works
- 2Health, Toxicology and Mutagenesis12% of their works
- 3Genetics7% of their works
- 4Molecular Biology5% of their works
- 5Physiology5% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Air Quality and Health Impacts
- Blood Coagulation and Thrombosis Mechanisms
- Blood properties and coagulation
- Chronic Lymphocytic Leukemia Research
- Venous Thromboembolism Diagnosis and Management
- Lymphoma Diagnosis and Treatment
- Cutaneous lymphoproliferative disorders research
- Hemophilia Treatment and Research
Which keywords describe Jan Emmerechts's research?
The keywords of their largest research topics: Hemostasis, Antithrombotic Therapy, Air Pollution, Particulate Matter, Rituximab, Prognostic Factors, Prophylaxis and Protease-Activated Receptors.
- Hemophilia
- Cutaneous Lymphomas
- Pulmonary Embolism
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Fibrinogen
- Protease-Activated Receptors
- Prognostic Factors
- Particulate Matter
- Antithrombotic Therapy
- Hemostasis
- Air Pollution
- Rituximab
- Prophylaxis
- Thrombin
- Transglutaminases
- Classification
- Lymphoma
- Venous Thromboembolism
- Factor VIII
- Mycosis Fungoides
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Hemostasis152 topics
- Antithrombotic Therapy142 topics
- Air Pollution131 topic
- Particulate Matter131 topic
- Rituximab102 topics
- Prognostic Factors92 topics
- Prophylaxis92 topics
- Protease-Activated Receptors91 topic
- Thrombin91 topic
- Fibrinogen61 topic
- Transglutaminases61 topic
- Chronic Lymphocytic Leukemia51 topic
- Classification51 topic
- Genomic Aberrations51 topic
- Lymphoma51 topic
- Pulmonary Embolism51 topic
- Venous Thromboembolism51 topic
- Cutaneous Lymphomas41 topic
- Factor VIII41 topic
- Hemophilia41 topic
- Mycosis Fungoides41 topic
Where does Jan Emmerechts work?
Jan Emmerechts's main affiliation in the publication record is AZ Sint-Jan, Belgium.
How many publications and citations does Jan Emmerechts have?
OpenAlex counts 55 works and 1,030 citations for Jan Emmerechts, an h-index of 16, ranking #4,015,229 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jan Emmerechts. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.